For the past 80 years, we have developed processes and technologies to support the discovery and development of treatments and cures for diseases like cancer, Parkinson’s, COVID-19, malaria, and other infectious diseases.
Infectious Disease & Pathogen
Pain & Substance Use
Antibody Drug Conjugates
Inactivated & Inactivated-Adjuvanted
7 FDA-approved cancer-fighting drugs developed with 20+ drugs in preclinical development.
Our scientists helped to quickly identify and refine one of the first approved treatments for COVID-19.
New treatments for illnesses ranging from Alzheimer’s to diabetes are being developed in collaboration with academic and commercial partners.
We have commercial, government, and industry partnership opportunities. Our work includes licensing patents, co-investing in furthering intellectual property, collaborating to create new intellectual property, and leveraging research to drive biotechnology product development.
March 17, 2023
May 16, 2022
January 24, 2022